Phase 3 Cold Clinical Trials

7 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 17 of 7 trials

Recruiting
Phase 3

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Chronic Inducible UrticariaCold UrticariaSymptomatic Dermographism+1 more
Celldex Therapeutics240 enrolled72 locationsNCT07266402
Recruiting
Phase 3

A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold

Common cold
Tasly Pharmaceutical Group Co., Ltd480 enrolled24 locationsNCT06697886
Recruiting
Phase 3

Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine

Common cold
Laboratorios Silanes S.A. de C.V.177 enrolled1 locationNCT06531707
Completed
Phase 3

A randomised controlled trial of the efficacy of a carrageenan nasal spray when taken during a cold in reducing asthma exacerbations as measured by the asthma control questionnaire.

Asthma exacerbation during a coldColds
Julian Crane360 enrolled1 locationACTRN12615001166561
Completed
Phase 3

Use of Carrageenan spray in the prevention of rhinovirus cold infection

Prevention of rhinovirus cold infection
Julian Crane80 enrolled1 locationACTRN12614000026628
Completed
Phase 3Phase 4

A study to evaluate the safety and efficacy of a complementary medicine formulation, to help relieve cold & flu symptoms and reduce duration of a cold, in otherwise healthy adults.

Treatment of InfluenzaTreatment of the Common Cold
A/Professor Luis Vitetta144 enrolled1 locationACTRN12612001199808
Completed
Phase 3

Ipratropium, Oxymetazoline or Pseudoephedrine in Coryza

Coryza (Common Cold)
Cold Study Unit, Royal Adelaide Hospital144 enrolled1 locationACTRN12606000482561